Cargando...
Pediatric Statin Administration: Navigating a Frontier with Limited Data
Increasingly, children and adolescents with dyslipidemia qualify for pharmacologic intervention. As they are for adults, 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors (statins) are the mainstay of pediatric dyslipidemia treatment when lifestyle modifications have failed. Despite the ov...
Guardado en:
| Publicado en: | J Pediatr Pharmacol Ther |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Pediatric Pharmacy Advocacy Group
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5103646/ https://ncbi.nlm.nih.gov/pubmed/27877092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-21.5.380 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|